Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy

por VEGA, GABRIEL G., FRANCO-CEA, LUZ ARELI, HUERTA-YEPEZ, SARA, MAYANI, HÉCTOR, MORRISON, SHERIE L., BONAVIDA, BENJAMIN, VEGA, MARIO I.
Publicado 2015

MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1

por Morales-Martinez, Mario, Vega, Gabriel G., Neri, Natividad, Nambo, M. J, Alvarado, Isabel, Cuadra, Ivonne, Duran-Padilla, M. A., Huerta-Yepez, Sara, Vega, Mario I.
Publicado 2020

P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma

por Vega, Gabriel G., Avilés-Salas, Alejandro, Chalapud, J. Ramón, Martinez-Paniagua, Melisa, Pelayo, Rosana, Mayani, Héctor, Hernandez-Pando, Rogelio, Martinez-Maza, Otoniel, Huerta-Yepez, Sara, Bonavida, Benjamin, Vega, Mario I.
Publicado 2015

Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma

por Morales-Martinez, Mario, Valencia-Hipolito, Alberto, Vega, Gabriel G., Neri, Natividad, Nambo, Maria J., Alvarado, Isabel, Cuadra, Ivonne, Duran-Padilla, Marco A., Martinez-Maza, Otoniel, Huerta-Yepez, Sara, Vega, Mario I.
Publicado 2019